GoofGoof
Premium Member
The CDC will also be taking the lead on distribution and partnering more with private industry. The issues with testing, especially in the beginning revolved around lab capacity. We won’t have that issue. The refrigeration could present a problem, but theres time for the companies to make the vaccine more stable at higher temperatures without impacting its effectiveness.I wouldn’t expect one to mimic the other at all. Logistically, they are completely different. Not to mention we have actually had experience with mass vaccine distribution. It’s gonna be a pain but it will be fine at be end. Well, once we have one.